Transactions November 17, 2017

Emblem Corp. Completes $28.8 Million Public Bought Deal Offering

Emblem Corp. (the “Company”), a Canadian licensed producer of medical cannabis, completed a bought deal public offering of units of the Company and convertible unsecured debentures of the Company for aggregate gross proceeds of approximatley$28.8 million (the “Offering”). The Offering was completed with a syndicate of underwriters led by Eight Capital and included Canaccord Genuity Corp., Echelon Wealth Partners Inc. and GMP Securities L.P. (collectively, the “Underwriters”).

Wildeboer Dellelce acted for the Underwriters in connection with the Offering with a team that included Jeff Hergott, Perry Dellelce, Danny Kharazmi, Amir Torabi and Tajrin Nayeem (corporate/securities) and Katy Pitch (tax).

 

 

Wildeboer Dellelce LLP